Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2026-06-03 21:04:59 ET · period of report 2026-06-01 · accession 0001193125-26-256126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-03 21:04 | 2026-06-01 | XENE | PATOU GARY | Dir | M - OptEx | — | +2,645 | 26.2K | +11% | — |
| D | 2026-06-03 21:04 | 2026-06-01 | XENE | PATOU GARY | Dir | M - OptEx | $0.00 | -2,645 | 0 | -100% | $0 |
| DM | 2026-06-03 21:04 | 2026-06-03 | XENE | PATOU GARY | Dir | A - Grant | $0.00 | +12.1K | 1,593 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-06-01 | M | A | 2,645 | — | 26,218 | D | — | — | (F1) Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. (F1) Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
| 2 | Derivative | Restricted Share Units | 2026-06-01 | M | D | 2,645 | $0.00 | 0 | D | — · — to — | 2,645 Common Shares | (F1) Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. (F1) Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. (F1) Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
| 3 | Derivative | Share Option (Right to Buy) | 2026-06-03 | A | A | 10,507 | $0.00 | 10,507 | D | $53.46 · — to 2036-06-02 | 10,507 Common Shares | (F3) Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
| 4 | Derivative | Restricted Share Units | 2026-06-03 | A | A | 1,593 | $0.00 | 1,593 | D | $0.00 · — to — | 1,593 Common Shares | (F4) Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. (F4) Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |